Aurora Cannabis Provides Key Updates on Business Transformation Plan

NYSE |TSX: ACB Continues to Execute on Corporate Restructuring & Facility Rationalization Plan Aimed at Margin Improvement and Profitability Exiting Fiscal Q4 2020 at an SG&A Run Rate of Approximately $42 Million Remains on Track for Positive Adjusted EBITDA in Fiscal Q1 2021 – Aurora Cannabis Inc. (the “Company” or “Aurora“) (NYSE |TSX: ACB), the Canadian company definingContinue reading “Aurora Cannabis Provides Key Updates on Business Transformation Plan”

Aurora Cannabis to Divest All Alcanna Shares Through a “Bought Deal”

9,200,000 common shares of the Company currently held by Aurora Cannabis at a price of $3.00 per Offered Share and offer them to the public Alcanna Inc. (TSX: CLIQ) and Aurora Cannabis Inc. (“Aurora“) (NYSE: ACB) (TSX: ACB) jointly announce that they have entered into an agreement with a syndicate of underwriters led by Cormark Securities Inc. (collectively, theContinue reading “Aurora Cannabis to Divest All Alcanna Shares Through a “Bought Deal””

Terry Booth Sells $1 Million Worth of Aurora Cannabis Shares

Aurora Cannabis’s (TSX: ACB, NYSE: ACB) former CEO Terry Booth dumped 48,000 shares at $21.28 in the public market on May 27, 2020. The transaction was filed on May 29, 2020. $21.28 x 48,000 shares = $1,021,440 Detailed Financials and Analysis of Aurora Cannabis About Aurora  Aurora is a global leader in the cannabis industryContinue reading “Terry Booth Sells $1 Million Worth of Aurora Cannabis Shares”

Aurora Cannabis Completes Acquisition of Reliva LLC

EDMONTON, May 28, 2020 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora“) (NYSE |TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced it has completed the previously announced acquisition of Reliva, LLC (“Reliva“) a leader in the sale of hemp-derived CBD products in the United States for approximately US$40 million of Aurora common shares. The transaction alsoContinue reading “Aurora Cannabis Completes Acquisition of Reliva LLC”

Aurora Cannabis Receives a New Price Target Boost

Cantor Fitzgerald boosted price target of Aurora Cannabis (NYSEE, TSX: ACB) to $27 from previous $22. The brokerage rated Aurora Cannabis from Market Perform to Overweight. 17 Wall Street analysts have issued ratings and price targets in the last 12 months. Average twelve month price target is $28.7, possible upside of 80.66% Highest price target:Continue reading “Aurora Cannabis Receives a New Price Target Boost”

Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform

NYSE | TSX: ACB All Share Transaction – Immediately Accretive to Shareholders on an Adjusted EBITDA Basis Profitable Today, Reliva Adds Strategic Entry to the U.S. that is Aligned to Aurora’s Business Transformation Plan Adds Miguel Martin, Veteran International Consumer Packaged Goods Executive to Aurora Management Team Reliva Provides Aurora with Top Ranked Retail Hemp-Derived CBDContinue reading “Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform”

Why Aurora Cananbis (NYSE: $ACB) is Surging Today

Shares of Aurora Cannabis (NYSE, TSX: ACB) rocketed as much as 70% intraday on Friday as investors embraced stronger than expected sales. Aurora also re-announced clearer path to profitability. Aurora Cannabis reported 35% quarterly net sales increase to $75.5 million recently. Aurora Cannabis narrowed its adjusted EBITDA loss – progress towards profitability. The company sawContinue reading “Why Aurora Cananbis (NYSE: $ACB) is Surging Today”

Aurora Cannabis (NYSE: $ACB) up 40% on Earnings Beat

Aurora Cannabis Inc.’s fiscal third-quarter numbers showed “encouraging signs, for a change,” according to Cantor Fitzgerald analyst Pablo Zuanic, who reiterated his overweight rating and C$22 ($16) stock price target in a Friday note. The Canadian company posted sales that were 13% above FactSet consensus, with recreational weed up 24% from the prior quarter, “and began toContinue reading “Aurora Cannabis (NYSE: $ACB) up 40% on Earnings Beat”

Aurora Cannabis (TSX: ACB) Gets a New Price Target Boost

May 13, 2020 Aurora Cannabis have received a boost in price target by Cantor Fitzgerald, the new price target is $22 per share. Rating remains overweight. Aurora cannabis (TSX, NYSE: ACB) recently went through a reverse split to keep compliance with NYSE share prices. 16 wall street analysts have issued ratings and price targets forContinue reading “Aurora Cannabis (TSX: ACB) Gets a New Price Target Boost”